Skip to main content
Technology
Organism-on-Chip
Biological model
Applications
Developmental Toxicity
Reproductive Toxicity
Aging
Motility Assays
Mode of Action
Neurodegeneration
Custom Assays
Services
News & Resources
News
Events
Resources
About
Team
Supporters
Careers
Contact
News
Category
All
Blog Post
News Article
Press Release
European Worm Meeting - Together for the C. elegans community
25/07/2022
- News Article
Nagi & MolGen in tandem at the European Worm Meeting 2022 at booth #5
Microfluidic Chips - Exploring the technology
20/07/2022
- Blog Post
Exploring the advantages of microfluidic chips for biological experiments.
Lab Automation - In search for efficiency
07/07/2022
- Blog Post
The quest for efficiency does not distinguish between industries. And labs are no exception. But, what does it implies to automate your lab?
A new approach to replace animal testing
23/06/2022
- News Article
Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
The future of drug and substance testing is ethical
16/06/2022
- Blog Post
The US House of Representatives passed the FDA Modernization Act to transform the drug approval process and move towards a non-animal testing future.
Nagi Bioscience and the future of labs
02/06/2022
- News Article
Meet the Organism-on-Chip that is revolutionizing the biotech sector in Nagi’s booth at Future Labs Live in Basel.
Santé ! Longévité !
30/05/2022
- News Article
Radio Télévision Suisse consulted our co-founder and CSO Laurent Mouchiroud about today’s advances in the field of aging and longevity research for the monthly health reportage.
Worm-on-Chip technology and its applications
19/05/2022
- Blog Post
From drug discovery to a possible future tool for lung cancer detection. How the Worm-on-chip is revolutionizing the alternative testing methods sector.
C. elegans in Cancer Research
12/05/2022
- Blog Post
How a tiny worm is helping to reveal the mystery of human tumors’ formation and the development of cancer drug candidates.
The 3Rs principle and animal testing
06/05/2022
- Blog Post
From the 3Rs model created in 1959 to today's animal welfare acts
Today is the day! Meet Nagi Bioscience at 2022 Swiss Biotech Day in Basel
02/05/2022
- News Article
We are delighted to announce our participation once again in the Swiss Biotech Day.
C. elegans in Aging Research
27/04/2022
- Blog Post
How C. elegans have been key in aging research crucial discoveries.
Nagi Bioscience at Longevity Leaders World Congress
22/04/2022
- News Article
Meet us at Longevity Leaders World Congress and learn more about our pioneer Organism-on-Chip technology
Nagi's Service Team is growing!
12/04/2022
- Blog Post
Meet Tiffany Rosa, Nagi's latest incorporation in our Service Team.
C. elegans and the Human Genome Project
08/04/2022
- Blog Post
How C. elegans contributed to the decoding of the human genome.
New team member alert!
06/04/2022
- Blog Post
Meet Rafael Marques, Nagi's new R&D Product Engineer.
Nagi Bioscience together with Bayer CropScience at the prestigious 2022 SOT Annual Meeting in San Diego
28/03/2022
- News Article
Our CSO and co-founder Laurent Mouchiroud will present Nagi's pioneer technology used in a successful project for Bayer CropScience at the prestigious SOT Annual Meeting.
Nagi Bioscience at TechTour Future22
23/03/2022
- News Article
Meet the first Organism-on-Chip technology on Friday 25th March at 14:30 CET at the TechTour Future22 event.
The SERI-funded EIC Accelerator program grants Nagi Bioscience with €2.5 million to accelerate development and commercial scale-up of their unique ‘Organism-on-Chip’ product
21/03/2022
- Press Release
Professing the transition to the new era of biological testing as our vision, being selected by the EIC Accelerator program is going to be crucial to make Nagi’s vision a reality.
Alternative Testing Methods
17/03/2022
- Blog Post
The new biotech horizon with an expected 10% annual growth from 2022 to 2025.
Meet our new Team Members!
10/03/2022
- Blog Post
The revolution of innovative and ethical biological testing counts today with three new talents!
The C. elegans Nobel Prizes
03/11/2021
- Blog Post
Learn more about the Nobel prizes that were awarded to c. elegans researchers.
How C. elegans can bridge the gap between cells and mouse
21/10/2021
- Blog Post
How c. elegans can be a sustainable and cost-effective solution bridging the gap between cells and vertebrates.
Nagi’s team is growing!
28/09/2021
- News Article
Our Nagi Bioscience’s team is expanding! We welcome Alexandre Vaudano, who will be working as an Intern in charge of Business Development and Marketing.
W.A. De Vigier Stiftung startup competition finalist
12/05/2021
- News Article
Nagi Bioscience was selected as a finalist of the prestigious W.A. De Vigier Stiftung startup competition in 2021.
Nagi Bioscience was selected as part of the EU funded "HealthAge" project
01/05/2021
- News Article
Nagi Bioscience was selected as part of the EU-funded “HealthAge” project.
Nagi Bioscience was awarded an Innosuisse Innovation Project in 2020
01/03/2021
- News Article
Nagi Bioscience was awarded an Innosuisse Innovation Project in 2020.
Nagi Bioscience was named as a TOP 100 Swiss startups and TOP 10 newcomers of 2020
09/09/2020
- News Article
Nagi Bioscience was named as a TOP 100 Swiss startups and TOP 10 newcomers of 2020. And we did it again this year 2022! We have been nominated for TOP 100 Swiss Start Ups 2022. Do you want to support us?
Nagi Bioscience listed in Bilan's TOP 50 Swiss start-up companies 2020!
11/03/2020
- News Article
Nagi Bioscience was selected by the prestigious Swiss economic newspaper Bilan among the Top 50 startups in which to invest in 2020.
Nagi Bioscience is proud to announce the closing of a CHF 1.8M seed financing round
20/12/2019
- Press Release
Nagi Bioscience raises CHF 1.8 Million to accelerate its mission of setting a new standard for testing safety and efficacy of drugs and chemicals.
Nagi Bioscience was attending the Demo Day at La Forge
23/05/2019
- News Article
Today, our CEO Matteo Cornaglia was on stage for pitching the company at the LaForge Startup Demo Day on EPFL campus.
A research grant funded by the Novartis Foundation
09/04/2019
- News Article
We are glad to announce that our application was accepted by the Novartis Foundation for Medical-Biological Research.
Nagi Bioscience won the Venture Kick final!
31/01/2019
- News Article
Nagi Bioscience wins the final phase of Venture Kick (130’000 CHF). The Venture Kick program has been an excellent support in terms of network, visibility and advices received from the coach and jury. Thank you Venture Kick&nbs
Our startup is finalist of the competition "Inventer Demain"
27/11/2018
- News Article
Nagi Bioscience is among the 20 finalists of the competition “Inventer Demain” organized by the RTS, France 3TV and Bilan magazine. Ten Swiss start-ups and ten other French companies are competing this year.
Nagi Bioscience won the Philip Morris Award Startup Competition!
12/10/2018
- News Article
We are proud to be the winner (CHF 10’000 cash prize) of the startup competition organized by Philip Morris Equity Partner! This competition, organized in the framework of MassChallenge Switzerland, aimed to support innov
Nagi Bioscience successfully passed Venture Kick Stage 2
29/06/2018
- News Article
Nagi Bioscience passed stage 2 of Venture Kick! Let’s continue on our way: stage 3, here we come!
Nagi Bioscience technology catches the attention in the Cosmic Field
29/06/2018
- News Article
According to the french web media Wydden, Nagi Bioscience is one of the 10 startups to follow in the BeautyTech industry! You can read the article published online by Wydden here. Good reading!
We are in the news!
09/06/2018
- News Article
Nagi Bioscience is featured today in the online version of French Economic TV channel BFMTV.
We are in the news!
29/05/2018
- News Article
Nagi Bioscience is featured today in the Economic Swiss newspaper Bilan. This article (in French) presents our startup and its device that avoids testing on animals for cosmetic, chemical industries and pharmas.
Nagi Bioscience is part of the 2018 MassChallenge acceleration program
24/05/2018
- News Article
We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program.
We are in the news!
20/05/2018
- News Article
Matteo and Laurent appeared respectively in two radio show broadcasted on the Swiss Radio RTS.
Nagi Bioscience won the PERL Biotech Award 2018
02/05/2018
- News Article
Our CSO Laurent Mouchiroud received the prestigious PERL (Prix Entreprendre Région Lausanne) Biotech Award 2018 during a ceremony held at the Theatre de Beaulieu in Lausanne. Each year, the PERL jury, made up of academic, e
Our technology is featured on the front page of the EPFL website
01/05/2018
- News Article
An interview with Matteo Cornaglia, our CEO, was published on te front page of the EPFL website, providing some insight about the how and why of the technology developed by Nagi Bioscience.
Matteo was selected for Venture Leaders Life Sciences 2018
05/04/2018
- News Article
Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team.
Nagi Bioscience passed Venture Kick stage 1
29/03/2018
- News Article
Great news: Nagi Bioscience passed stage 1 of Venture Kick!
Nagi Bioscience listed in Bilan's TOP 50 Swiss start-up companies!
28/02/2018
- News Article
We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of the most promising StartUps in Switzerla
We are in the news!
02/11/2017
- News Article
Nagi Bioscience is featured today in the Swiss newspaper Le Temps. This article (in French) discusses the current problematic of animal testing in the scientific research and highlight the solution developed by Nagi Bioscience.
Nagi Bioscience at the Hello Tomorrow Summit in Paris
25/10/2017
- News Article
From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups.
Our technology will be presented at ILMAC Lausanne 2017
19/09/2017
- News Article
We are delighted to announce that our team will pitch the technology developed by Nagi Bioscience during the ILMAC Lausanne exhibition on Thursday, the 5th of October. The first-ever edition of ILMAC LAUSANNE is taking place
Nagi Bioscience results presented at Eurotox 2017 conference in Bratislava
14/09/2017
- News Article
From September 10th to 13th, Nagi Bioscience attended the 53rd Congress of the European Societies of Toxicology (EuroTox) in Bratislava. Our team presented for the first time a poster with the latest results obtained in colla
We made it to the top 500 in the Hello Tomorrow Global Challenge!
14/07/2017
- News Article
We are delighted to announce that Nagi Bioscience has been chosen by Hello Tomorrow as one of the world’s TOP 500 deep-tech startups! Hello Tomorrow is a global not-for-profit organization created by deep tech entreprene
A collaborative study between the University of Melbourne (Prof. Gasser's Lab) and the Nagi Bioscience team was published today
10/07/2017
- News Article
We are happy to announce the release of a new publication in collaboration with the Laboratory of Prof.
The platform developed by Nagi Bioscience is featured on the website of the Swiss Laboratory Animal Association (SGV)
23/06/2017
- News Article
In 2015, the project developed by Nagi Bioscience was the first recipient of the SGV 25th Fund.
Nagi Bioscience ranked TOP 10 at "Venture.ch" business plan competition
22/06/2017
- News Article
Our Business Plan was awarded as TOP 10, among 108 submitted projects! »Venture» is Switzerland’s premier startup competition, initiative of ETH Zurich, EPF Lausanne, Knecht Holding, the innovation promotion agency CTI and M
Nagi Bioscience wins the Egon Naef Award 2017
25/03/2017
- News Article
This prestigious prize is given annually by the “E. Naef Foundation for in vitro research” (FENRIV), established in 1998.
Nagi Bioscience receives financial support from the Gebert Rüf Stiftung
04/11/2016
- News Article
Gebert Rüf Stiftung fosters innovations for the benefit of Swiss economy and society, by supporting application-oriented and impact-oriented scientific projects at Swiss universities.
Our last paper is featured on the EPFL website
15/02/2016
- News Article
The EPFL website and the Swiss French Radio (RTS) have covered the publication of our last scientific paper.
Nagi Bioscience ranks TOP 10 at “venture.ch” business idea competition
15/06/2015
- News Article
Our Business Idea (formerly known as Nematrix) was selected by the Jury Committee of >>venture>> 2015,out of a total of 107 submissions, as a TOP 10 winner of the business idea competition!
Start your next project with us and join a new era in biological testing
Contact one of our experts today
